` Comparison: WEGE3 vs ABBN - Alpha Spread

WEGE3
vs
ABBN

Over the past 12 months, WEGE3 has underperformed ABBN, delivering a return of +15% compared to the ABBN's +74% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
WEGE3
ABBN
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

WEGE3 Intrinsic Value
LOCKED
Unlock
ABBN Intrinsic Value
LOCKED
Unlock
Company Last Price Intrinsic Value DCF Value Multiples-Based Value Wall St Target
WEG SA
BOVESPA:WEGE3
52.88 BRL
Abb Ltd
SIX:ABBN
71.94 CHF
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
WEGE3, ABBN

WEGE3
ABBN
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
WEG SA
Revenue
Abb Ltd
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
WEGE3, ABBN

WEGE3
ABBN
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
WEG SA
BOVESPA:WEGE3
Abb Ltd
SIX:ABBN
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

WEGE3
33.5%
ABBN
41.1%
LTM 3Y Avg 5Y Avg 10Y Avg
WEG SA
Abb Ltd

Operating Margin

WEGE3
19.5%
ABBN
17.7%
LTM 3Y Avg 5Y Avg 10Y Avg
WEG SA
Abb Ltd

Net Margin

WEGE3
15.6%
ABBN
14.2%
LTM 3Y Avg 5Y Avg 10Y Avg
WEG SA
Abb Ltd

FCF Margin

WEGE3
9.5%
ABBN
13.5%
LTM 3Y Avg 5Y Avg 10Y Avg
WEG SA
Abb Ltd

ROE

WEGE3
32.2%
ABBN
31%
LTM 3Y Avg 5Y Avg 10Y Avg
WEG SA
Abb Ltd

ROA

WEGE3
15.2%
ABBN
11.1%
LTM 3Y Avg 5Y Avg 10Y Avg
WEG SA
Abb Ltd

ROIC

WEGE3
21.3%
ABBN
14.1%
LTM 3Y Avg 5Y Avg 10Y Avg
WEG SA
Abb Ltd

ROCE

WEGE3
31.1%
ABBN
22%
LTM 3Y Avg 5Y Avg 10Y Avg
WEG SA
Abb Ltd

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
WEGE3, ABBN

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
WEGE3, ABBN

Performance Gap Between WEGE3 and ABBN
LOCKED
Unlock

Performance By Year
WEGE3, ABBN

Loading
WEGE3
ABBN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare WEGE3 to other stocks
300750
Contemporary Amperex Technolog...
Cheaper
vs WEGE3
SU
Schneider Electric SE
Cheaper
vs WEGE3
ETN
Eaton Corporation PLC
Cheaper
vs WEGE3
VRT
Vertiv Holdings Co
More expensive
vs WEGE3
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett